Solutions

Online Inquiry

Prostate Cancer Organoid Development

Prostate cancer organoids can mimic the growth and development process of prostate tissue and can be used to study the mechanisms of prostate cancer onset and progression. Alfa Cytology provides comprehensive services for the development of prostate cancer organoids, ensuring that your research endeavors are carried out with utmost efficiency and accuracy.

Introduction to Prostate Cancer Organoids

Organoids are in vitro three-dimensional (3D) cultured tissue analogs that are cultured using adult or pluripotent stem cells and are able to mimic real organs in structure and function. Prostate cancer organoids can mimic the growth and development of prostate tissue and can be used to study the mechanisms of prostate cancer onset and progression. It can also be used to study many different aspects of prostate biology, including homeostasis, tumorigenesis and drug discovery.

Fig. 1 Organoids from primary PCa retain features of originating tumor. (Pamarthy, S., et al. 2021)Fig. 1 Organoids from primary PCa retain features of originating tumor. (Pamarthy, S., et al. 2021)

Prostate cancer organoids provide researchers with an exciting new tool to test cancer drugs and individualize cancer therapies. In addition, the application of prostate cancer organoid technology in mechanistic studies and translational medicine is recognized as a promising approach to facilitate the development of potential biomarkers and novel therapeutic strategies.

Source of Prostate Cancer Organoids

Prostate cancer organoids can be generated from healthy mouse and human prostates, metastatic prostate cancer lesions, and circulating tumor cells. Starting with cultures of digested tissue material, fully grown organoids are usually obtained within 2 weeks.

  • Circulating tumor cells
  • Prostate cancer biopsy samples
  • Metastatic prostate cancer lesions

Our Services

Alfa Cytology offers comprehensive prostate cancer organoid development services. Our experts have experience and expertise to customize 3D organoid models to meet your specific needs in prostate cancer research through the use of advanced technologies and methodologies. These organoids not only mimic the complexity of the tumor, but also maintain highly similar genetic and phenotypic characteristics to the original tumor.

Organoid Customization

Organoid design involves selecting appropriate cell sources, optimizing culture conditions, and incorporating specific genetic modification or labeling techniques as needed.

Organoid Formation

Employ state-of-the-art prostate cancer organoid culture platform to obtain organoids capable of mimicking specific prostate cancer types.

Functional Analysis

Offer HE staining and other methods to test similarities between prostate cancer tissues and organoids in terms of nucleus and cytoplasmic color, nuclear-to-plasmic ratio, and cellular arrangement are observed. A range of functional assays are also available to assess organoid responses to stimuli, evaluate differentiation potential, analyze gene expression profiles, and perform drug screening studies.

Delivery Results

Deliver prostate cancer organoids that are carefully grown, along with detailed reports that confirm their authenticity and high standards. Our commitment to punctual delivery is driven by our meticulous attention to detail and our passion for supporting your research.

With extensive experience and advanced platforms, we offers a one-stop prostate cancer organoid development service. We guarantee that your research endeavors are equipped with superior, dependable prostate cancer organoid models. If you are interested in our services, please don't hesitate to contact us for further information and pricing details.

Reference

  1. Pamarthy, S., et al. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine. Molecular cancer. 2021, 20(1): 125.
notification For research use only.

Related Services